HLA-G class I gene expression in normal and malignant hematopoietic cells

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The Human Leukocyte Antigen-G (HLA-G) molecule is primarily expressed in placental cells and plays a role in fetomaternal tolerance through interactions with KIR receptors on decidual NK cells.
• Investigating HLA-G's potential role in immune tolerance during cancer is crucial for understanding tumor immune evasion strategies.

Purpose of the Study:

• To compare HLA-G gene expression in normal versus malignant hematopoietic cells.
• To determine if HLA-G presence contributes to immune tolerance in the context of cancer.

Main Methods:

• Analysis of HLA-G gene expression in various normal and malignant hematopoietic cells.
• Utilized the specific HLA-G monoclonal antibody (mAb) 87G to detect cell surface and intracellular HLA-G antigens.
• Cytokine treatment of the U937 monohistiocytic cell line to assess induction of HLA-G expression.

Main Results:

• HLA-G transcriptional activity was detected in lymphocytes and monocytes, but no HLA-G antigens were found at the cell surface or in the cytosol.
• This lack of surface/cytosolic HLA-G expression remained consistent in malignant hematopoietic cells.
• Treatment with cytokines successfully induced HLA-G antigen expression in the U937 cell line.

Conclusions:

• Despite transcriptional activity, HLA-G antigens are generally not expressed on normal or malignant hematopoietic cells.
• Cytokine-induced HLA-G expression in monocytic malignant cells suggests a potential mechanism for immune tolerance in cancer patients.